Background and Purpose-Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication. Methods-All patients were administered intravenous alteplase with/without intra-arterial therapy. An age-and sex-matched case-control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24-to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min•per 100 g, relative volume of T max ≥16 s with all volumes standardized to z axis coverage, mean permeability surface area product values within T max ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status). Results-One-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade (P<0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume (P=0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63-0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6). Conclusions-Baseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase.
I
ntracerebral hemorrhage (ICH) is a feared complication of acute ischemic stroke treatment with intravenous alteplase. [1] [2] [3] [4] [5] [6] [7] Severe ischemia over a sustained period of time increases the risk of endothelial injury and blood-brain barrier breakdown, leading to hemorrhage within ischemic brain tissue. Imaging markers of severe ischemia include hypoattenuation on noncontrast computed tomography (NCCT) and very low cerebral blood volume (vlCBV) on perfusion imaging. 8 Imaging markers of impaired blood-brain barrier permeability include the permeability surface area product (PS) measured on computerized tomography perfusion (CTP). 9 Clinical variables such as stroke severity are surrogate markers of ischemia severity, whereas biochemical variables such as raised blood glucose are associated with increased risk of blood-brain barrier permeability and ischemia severity. 2, 6 High blood pressure may modify the effect of severe ischemia and blood-brain barrier disruption on hemorrhage development by increasing perfusion pressure. 2 Finally, reperfusion may contribute to ICH development, particularly when reperfusion occurs into severely ischemic brain tissue. 7, 10 Although studies in the past have used some or many of these clinical and imaging variables, very few studies have combined detailed analysis of multimodal imaging with clinical and laboratory data and reperfusion status to determine the risk of hemorrhage after alteplase administration. Moreover, although NCCT extent of ischemia has been studied extensively along with vlCBV and blood-brain barrier permeability surface product on CTP, severity of hypoattenuation on NCCT, a marker of severity of ischemia, and time of exposure to that ischemia have never been analyzed in detail. In a sample of patients treated with intravenous alteplase, we analyze association between multimodal CT imaging parameters, including NCCT hypoattenuation degree, vlCBV, impaired blood-brain barrier permeability surface product, clinical and laboratory data at baseline, early reperfusion status, and development of parenchymal hemorrhage (PH) on follow-up imaging.
Methods
Data were obtained from multiple stroke centers between 2009 and 2015 and approved by the respective local ethics review boards. Each patient underwent a stroke imaging protocol consisting of NCCT, CT angiography, and CTP at baseline. Follow-up NCCT or magnetic resonance imaging was obtained within 24 to 48 hours. Inclusion criteria consisted of (1) patients presenting with signs and symptoms of acute ischemic stroke of the anterior circulation, (2) age ≥18 years, (3) 2-phase CTP acquisition duration 120 to 150 s for adequate permeability surface area product calculation, and (4) treatment with intravenous alteplase (with or without endovascular thrombectomy).
All patients underwent a CT stroke protocol performed at admission using a 64-detector row scanner that consisted of an NCCT head, a contrast-enhanced CT angiography arch to vertex, and CTP head. A maximum volume of 40 to 50 mL of CT contrast agent was injected for CT angiography, whereas 45 mL was injected at 4.5 mL/s followed by a saline chase of 40 mL at 6 mL/s for CTP. Z-plane coverage of 8 cm (n=95) or 4 cm (n=39) was acquired at 5 mm slice thickness. Scanning using a 2-phase protocol began after a delay of 5 s from contrast injection: phase 1 (2.8-s interval for 45-60 s) and phase 2 (15-s intervals for 90 s).
Image Analysis
Readers blinded to other imaging and patient outcomes performed all image analyses. All NCCT scans were scored for Alberta Stroke Program Early CT Score (ASPECTS). Another reader assessed degree of hypoattenuation within the ischemic region using a 3-point grading system (grade 1-subtle attenuation; grade 2-grey matter density of early ischemic change similar to that of contralateral white matter, and grade 3-grey matter density of early ischemic change less than that of contralateral white matter; Figure) . If the affected ischemic region had heterogeneous density, a higher grade was scored only if degree of attenuation of that grade occupied >one third of the affected region. Interrater reliability for NCCT hypoattenuation grade between an expert and a trainee rater was measured using Fleiss κ.
Functional parametric maps of cerebral blood flow (CBF), CBV, T max , and PS were processed using CTP 4D (GE Healthcare, Waukesha, WI), and a modified CTP algorithm for permeability calculations was used as described previously. 9 For each study, the arterial input function was manually selected from the basilar artery, internal carotid artery, or anterior cerebral artery using a 2×2 voxel (in-slice) region of interest. All CTP postprocessing was done using custom in-house software. 11 The following CTP variables were then calculated from the CTP functional maps: (1) rvlCBV determined by calculating the CBV value from the lower 2.5th percentile of the contralesional hemisphere CBV distribution and then applying this value to the ipsilesional hemisphere within an ischemic territory denoted by a T max ≥8 s to get a brain volume. The rvlCBV (a ratio standardized to CTP z axis coverage) was obtained by dividing this volume by total ipsilesional hemisphere volume from 4 cm or 8 cm coverages, (2) relative volume of low CBF (rvCBF) determined by calculating the ipsilesional hemisphere volume with CBF ≤7 mL/min•per 100 g again standardized to z axis coverage, 11 (3) relative volume of prolonged T max determined by calculating the ipsilesional hemisphere volume with T max ≥16 s standardized to z axis coverage, 11 (4) PS ischemia -mean PS values (mL/min per•100 g) from within the T max ≥8 s volume (ie, permeability within ischemic tissue), and (5) PS total -mean PS values (mL/min per•100 g] within the entire ipsilesional hemisphere. Gray matter and white matter values were obtained separately for all CTP variables by applying patient-specific HU thresholds to the CTP average map, while excluding cerebrospinal fluid, ventricles, choroid plexus, and large vessels.
An expert assessed reperfusion/recanalization on conventional angiography at end of endovascular therapy using the modified thrombolysis in cerebral infarction or on repeat CT angiography using the modified arterial occlusive lesion scale in patients receiving intravenous alteplase alone. 12 All patients were assessed for the presence of hemorrhage on 24-to 48-hour magnetic resonance imaging or NCCT using ECASS II criteria (European Cooperative Acute Stroke Study).
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Statistical Design and Analysis
Symptomatic ICH is a rare event after current intravenous alteplase treatment with prevalence rates ranging from 1% to 4% in recent studies.
14 Rates of PH (PH2 or PH1 as per ECASS II classification) are also low. 14 The rarity of symptomatic ICH or even PH (<10% prevalence), the smaller sample sizes available with detailed multimodal imaging, and the large number of predictor variables of interest mean that statistical models run the risk of over fitting and consequent type 1 errors. To mitigate this problem while at the same time retaining the ability to analyze multimodal imaging and clinical variables together, we used a case-control framework to include all subjects from the database with the primary outcome of interest Figure. NCCT hypoattenuation grade (grade 1-subtle attenuation; grade 2-density of early ischemic change similar to that of contralateral white matter, and grade 3-density of early ischemic change less than that of contralateral white matter). CT indicates computed tomography; and CTA, computed tomographic angiography.
(PH as per ECASS II classification) fulfilling study eligibility criteria (cases). Because there were only 22 subjects with PH fulfilling all eligibility criteria in the database, we planned to select around 100 subjects matched for age (≤60, 60-70, 70-80, and > 80 years) and sex without PH fulfilling study eligibility criteria (controls; Table 1 ). Exposure variables of interest included baseline stroke severity (NIHSS), stroke onset to CTP imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, intraarterial treatment, reperfusion status, and imaging variables NCCT ASPECTS, rvlCBV, rvCBF , relative volume of prolonged T max , PS ischemia. and PS total . Spearman correlation among all exposure variables was explored using nonparametric statistics (Tables I and II in  the online-only Data Supplement) To avoid over fitting multivariable logistic regression models, univariate association between exposure variables and the primary outcome was assessed, and only variables found to be statistically significant at a 2-sided P value of <0.2 were included in further multivariable modeling. Because PH % was not different between NCCT hypoattenuation grades 2 and 3, they were combined into 1 category and compared with grade 1 hypoattenuation. Two statistical models were constructed, one that used gray matter derived CTP variables (model 1) and another that used white matter derived CTP variables (model 2). Stepwise backward regression with elimination followed by the likelihood ratio test was used to arrive at the most parsimonious model in which all predictor variables were statistically significant at a 2-sided P<0.05. Multicollinearity was assessed among exposure variables using the variance inflation factor. Receiver operating characteristic curves were plotted for the final logistic regression models and the area under the curve reported. Models 1 and 2 were compared using the Akaike Information Criterion and Bayesian Information Criterion. Sensitivity analyses as above were attempted on the entire sample using conditional logistic regression. Another sensitivity analyses was attempted in early presenters, that is, patients with stroke onset to CTP time ≤180 minutes.
Results
One-hundred eighteen subjects (22 patients with PH versus 96 without, mean age 71.9±13 years) were included in the final analysis. Median baseline NIHSS was 15 (interquartile range, 12), median NCCT ASPECTS was 8 (interquartile range, 4), and median stroke onset to imaging time was 112 minutes (interquartile range, 78 minutes). Baseline clinical and imaging characteristics of patients with and without PH are summarized in Table 1 . Distribution of ICH after intravenous alteplase treatment as per ECASS II classification is hemorrhagic infarction 1 (n=21), hemorrhagic infarction 2 (n=9), PH 1 (n=13), and PH2 (n=9). No subject had remote PH. The proportion of PH versus no PH in subjects with NCCT hypoattenuation grade 2 or 3 was 4× that in patients with hypoattenuation grade 1 (29.5% versus 7%; P<0.001). Interrater reliability for NCCT hypoattenuation grade assessment in 51 subjects between 2 raters was moderate as per Fleiss template (κ=0.6, agreement 76%).
Modest correlations were noted between baseline NCCT ASPECTS, hypoattenuation grade, and NIHSS. Modest to weak correlations were also noted between baseline NIHSS and CTP measures rvlCBV, rvCBF in gray and white matter. Correlation between permeability measures and other variables was weak (See Correlation Matrix between all exposure variables in Tables I and II in Criterion, 112.5). Sensitivity analyses using conditional logistic regression show similar results (Table III in the onlineonly Data Supplement). In subgroup analyses restricted to subjects with stroke onset to CTP time ≤180 minutes (n=94), NCCT hypoattenuation grade (P=0.009) was the only significant imaging variable in both models 1 and 2.
Discussion
Our results show that NCCT hypoattenuation within ischemic brain that is similar to or lower than contralateral white matter and vlCBV measured within white matter using CTP is associated with risk of PH after intravenous alteplase treatment. Other imaging and clinical variables (some significant in univariate analyses) were not associated with risk of PH after intravenous alteplase treatment. Risk prediction scores in the past have used imaging markers to determine risk of ICH after intravenous alteplase treatment. 3, 6 Extent of infarction measured on NCCT using the ASPECTS score or the one-third MCA rule was shown in some studies to be modestly associated with ICH risk. 3, 6 These studies did not assess degree of hypoattenuation within ischemic brain. Pathological studies suggest that endothelial injury, impaired blood-brain permeability, and consequent hemorrhage develop over time in severely ischemic brain parenchyma. 10 Hypoattenuation degree too develops over time; severely ischemic brain parenchyma will develop hypoattenuation earlier than brain with less severe ischemia. 15 NCCT hypoattenuation degree is therefore a better marker of ischemia severity and time than hypoattenuation extent. [15] [16] [17] NCCT attenuation drops over time, whereas the infarct grows in size; this explains the modest correlation we see between NCCT hypoattenuation grade and ASPECTS at baseline. Our results support this premise and suggest that the contralateral white matter is a practical reference for physicians to assess degree of hypoattenuation and risk of PH with intravenous alteplase treatment.
An imaging variable like vlCBV on CTP also measures ischemia severity. 18 Multiple studies in the past have shown the use of vlCBV in determining risk of hemorrhage after intravenous alteplase treatment. 8, 18, 19 Our results provide further supporting evidence of the value of this imaging variable. Although regions with very low CBV may develop greater degree of hypoattenuation on NCCT over time, our results only showed a weak association between these 2 variables. Very early presenters may have brain regions with vlCBV, but because brain has not been exposed to ischemia for long, hypoattenuation on NCCT may not have developed and endothelial injury and blood-brain barrier disruption may not have set in. On the other hand, the development of endothelial injury and blood-brain barrier disruption may temporally precede the development of hypoattenuation on NCCT, thus resulting in this variable having additional use over and above NCCT hypoattenuation degree in determining PH risk (especially in early presenters). Our results suggest an additional use of vlCBV (measured in white matter) along with NCCT hypoattenuation in determining PH risk. Although we did not show an advantage of vlCBV over NCCT in determining PH risk in early presenters (≤180 minutes from stroke symptom onset), future studies with larger samples may do so.
CTP algorithms are also capable of measuring blood-brain barrier permeability surface product (PS ischemia ). 9 Previous studies have shown the use of blood-brain barrier permeability measures like PS ischemia in determining risk of ICH after intravenous alteplase treatment. 9, 20 The endothelium and blood-brain barrier could be prone to leakiness in patients with diabetes mellitus, a history of smoking, or hypertension. Mechanisms include dysfunctional calcium signaling, disruption of tight junctions, and basement membrane degradation by enzymes such as matrix metalloproteinase and vascular endothelial growth factor. [21] [22] [23] [24] Ischemic brain may therefore have vasculature with impaired permeability even with mild hypoattenuation on NCCT and normal CBV on CTP. Although our results show statistically significant but weak association between PS ischemia and other imaging variables, we were unable to demonstrate use of measuring blood-brain barrier permeability in determining risk of hemorrhage after intravenous alteplase treatment independent of imaging variables NCCT hypoattenuation and very low CBV.
Our study has limitations. The case-control nature of our study design and the analyses techniques we used are robust to determine association between exposure and outcome when the outcome is rare. 25 Our results should not however be used to estimate prevalence of outcome, attributable risk from exposure or causation. Larger sample sizes and more robust statistical techniques such as support vector machines or other machine learning techniques are essential if we are to analyze predictors of rare events such as PH2 or symptomatic ICH (clinically more relevant than PH) and if we intend to explore the rich interactions likely present between various predictor variables in determining risk of hemorrhage after intravenous alteplase treatment. We measured overall reperfusion into ischemic territory at an early time point after treatment administration and found that this variable was not associated with risk of hemorrhage. It is likely that late and local reperfusion is better associated with hemorrhage risk than early reperfusion. Interrater reliability when measuring NCCT hypoattenuation between an expert and a trainee reader was moderate, suggesting that these readings need some expertise.
Measuring CBV is also prone to error. 26 In contrast to the study by Yassi et al that used an acquisition protocol of 60 s, our scanning used a more prolonged acquisition protocol of around 150 s, that is, phase 1 (2.8-s interval for 45-60 s) and phase 2 (15-s intervals for 90 s). This potentially minimizes truncation error that is known to cause underestimation of CBV and may explain why Yassi et al 26 did not find PH associated with the rCBV volume. Although the 2-phase perfusion we used prevented truncation error, the use of the Johnson-Wilson-Lee model avoided overestimation of CBV from possible disruption of the blood-brain barrier in our study. 27 The CTP algorithm that Yassi et al 26 used was delay sensitive standard singular value decomposition that could potentially underestimate CBF in ischemic region but not in the normal hemisphere (used as the reference in regional cerebral blood flow calculation). This preferential underestimation of ischemic but not normal CBF may explain why the association of regional cerebral blood flow volume with PH was not as strong as that using T max in that study. In contrast, T max as used in Yassi et al 26 study was not relative to the normal hemisphere. As such, even though T max determined with a delay sensitive algorithm for an ischemic region could be overestimated, this effect is less than that on regional cerebral blood flow. This likely explains why the volume of T max >14 s was most strongly associated with PH in that study. In addition, our study also used a CTP average map with signal:noise ratio and image quality similar to magnetic resonance imaging to segment grey from white matter from HU thresholds and evaluating grey versus white matter CTP parameters separately. 27, 28 Finally, prediction of treatment complications such as PH alone may not address the question of risk versus benefit with treatment. Developing and validating better automated software capable of measuring NCCT hypoattenuation and CTP imaging variables might help in making such risk prediction exercises available for future use. In conclusion, hypoattenuation on NCCT and very low CBV on CTP are useful in determining risk of hemorrhage in patients with acute ischemic stroke otherwise eligible for treatment with intravenous alteplase. Larger studies are needed before we derive prediction rules that can reliably change clinical practice.
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